Indeed, STAT3 activation has been previously implicated in the pathogenesis of AIDS-NHL [18], and in many other cancers including breast cancer, multiple myeloma, head and neck cancer, leukemias, lymphomas, lung cancer and prostate cancer [41-46]. Here, STAT3 is linked to non-Hodgkin lymphoma.